Skip to main content
SpringerLink
Log in

Drugs to Limit Use of or Avoid when Performing Liposuction

  • Chapter
Liposuction

  • 1866 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 439.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Physicians’ Desk Reference, 52nd Edition. 1998:3070

    Google Scholar 

  2. Shiffman, M.A.: Guidelines for the prevention of venous thromboembolism. Am J Cosmet Surg 2000;17(2):103–104

    Google Scholar 

  3. Vessey, M., Mant, D., Smith, A., Yeates, D.: Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J 1986;292(6519):526

    Article  CAS  Google Scholar 

  4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Venous thromboembolic disease and combined oral contraceptives: results of an international multicentre case-controlled study. Lancet 1995;133:1575–1582

    Google Scholar 

  5. Gerstman, B.B., Piper, J.M., Tomita, D.K., Ferguson, W.J., Stadel, B.V., Lundin, F.E.: Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991;133:32–37

    PubMed  CAS  Google Scholar 

  6. Carr, B., Ory, H.: Estrogen and progestin components of oral contraceptives relationship to vascular disease. Contraception 1997;55:267–272

    Article  PubMed  CAS  Google Scholar 

  7. Boston Collaborative Drug Surveillance Program: Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med 1974;290:15–19

    Article  Google Scholar 

  8. Petitti, D.B., Wingerd, J., Pellegrin, F., Ramcharan, S.: Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. J Amer Med Assoc 1979;242:1150–1154

    Article  CAS  Google Scholar 

  9. Devor, M., Barrett-Connor, E., Renvall, M., Feigal, D.J., Ramsdell, J.: Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 1992;92:275–282

    Article  PubMed  CAS  Google Scholar 

  10. Nachtigall, L.E., Nachtigall, R.H., Nachtigal, R.D., Beckman, E.M.: Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979;54:74–79

    Article  PubMed  CAS  Google Scholar 

  11. Daly, E., Vessey, M.P., Hawkins, M.M., Carson, J.L., Gough, P., Marsh, S.: Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977–980

    Article  PubMed  CAS  Google Scholar 

  12. Barrett-Connor, D.M., Renvall, M., Ramsdell, J.: Estrogen replacement and the risk of venous thrombosis. Am J Med 1992;92(3):275–282

    Article  PubMed  Google Scholar 

  13. Jick, H., Derby, L.E., Myers, M.W., Vasilakis, C., Newton, K.M.: Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996;348:981–983

    Article  PubMed  CAS  Google Scholar 

  14. Grodstein, F., Stampfer, M.J., Goldhaber, S.Z., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C., Hennekens, C.H.: Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996;348:983–987

    Article  PubMed  CAS  Google Scholar 

  15. Perez Gutthann, S., Garcia Rodriguez, L., Castellsague, J., Duque Oliart, A.: Hormone replacement therapy and the risk of venous thromboembolism: population based case-control study. Br Med J 1997;314:796–800

    CAS  Google Scholar 

  16. Varas-Lorenzo, C., Garcia-Rodriguez, L., Cattaruzzi, C., Troncon, M.G., Agostinis, L., Perez-Gutthann, S.: Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol 1998;147:387–390

    PubMed  CAS  Google Scholar 

  17. Grady, D., Hulley, S.B., Furberg, C.: Venous thromboembolic events associated with hormone replacement therapy. JAMA 1997;278:477

    Article  PubMed  CAS  Google Scholar 

  18. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., Vittinghoff, E.: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605–613

    Article  PubMed  CAS  Google Scholar 

  19. Grady, D., Wenger, N.K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S.: Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen/progestin Replacement Study. Ann Int Med 2000;132(9):689–696

    PubMed  CAS  Google Scholar 

  20. Rosenson, R.S., Tangney, C.C.: Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. J Amer Med Assoc 1996;279(20):1643–1650

    Article  Google Scholar 

  21. Mullins, R.: Quoted by Woznicki, A.: Herbs. In Readers Digest, 2000;July;49–51

    Google Scholar 

  22. Fugh-Berman, A.: Herb-drug interactions. Lancet 2000;355:134–135

    Article  PubMed  CAS  Google Scholar 

  23. Windrum, P., Hull, D.R., Morris, T.C.M.: Herb-drug interactions. Lancet 2000;355:1019–1020

    Article  PubMed  CAS  Google Scholar 

  24. Herbs and Health: Harvard Heart Lett 2000;10(7):3–4

    Google Scholar 

  25. PDR for Herbal Medications, first edition. Montvale, New Jersey, Medical Economics Company, 1998

    Google Scholar 

  26. Kaye, A.: Quoted by Davis, R.: Dangers of Herbals. In USA Today 2000;May 30:1A

    Google Scholar 

  27. Cherken, L.: What you don’t know about herbs and drugs can hurt you. Family Circle 2000;Sept. 12:90

    Google Scholar 

  28. Baumann, T.J.: Place of ketorolac in pain management. Clin Pharm 1990;9:938

    PubMed  CAS  Google Scholar 

  29. Cataldo, P.A., Senagore, A.J., Kilbride, M.J.: Ketorolac and patient controlled analgesia in the treatment of postoperative pain. Surg Gynecol Obstet 1993;176:435–438

    PubMed  CAS  Google Scholar 

  30. Freie, H.M.: Treatment of moderate and severe pain. Ketorolac—a new analgesic. Fortschr Med 1991;109:643–646

    PubMed  CAS  Google Scholar 

  31. O’Donovan, S., Ferrara, A., Larach, S., Williamson, P.: Intraoperative use of Toradol facilitates outpatient hemorrhoidectomy. Dis Colon Rectum 1994;37:793–799

    Article  PubMed  CAS  Google Scholar 

  32. Richman, I.M.: Use of Toradol in anorectal surgery. Dis Colon Rectum 1993;36:295–296

    Article  PubMed  CAS  Google Scholar 

  33. Spindler, J.S., Mehlisch, D., Brown, C.R.: Intraoperative ketorolac and morphine in the treatment of moderate to severe pain after major surgery. Pharmacotherapy 1990;10:51–58

    Google Scholar 

  34. Stanski, D.R., Cherry, C., Bradley, R. et al: Efficacy and safety of single doses of intramuscular ketorolac tromethane compared with meperidine for postoperative pain. Pharmacotherapy 1990;10:40–44

    Google Scholar 

  35. Gorcha, I.S., Bostwick, J.: Postoperative hematomas associated with Toradol. Plast Reconstr Surg 1991;88(5):919–920

    Article  Google Scholar 

  36. Conrad, K.A., Fagan, T.C., Mackie, M.J., Mayshar, P.V.: Effects of ketorolac tromethamine on hemostasis in volunteers. Clin Pharmacol Ther 1988;43(5):542–546

    Article  PubMed  CAS  Google Scholar 

  37. Concannon, M.J., Welsh, C.F., Puckett, C.L.: Inhibition of perioperative platelet aggregation using Toradol (ketorolac). South Med J 1991;84:S2–72

    Google Scholar 

  38. Pearce, C.J., Gonzalez, F.M., Wallin, D.: Renal failure and hyperkalemia associated with ketorolac tromethamine. Arch Int Med 1993;153:1000–1002

    Article  CAS  Google Scholar 

  39. Physicians’ Desk Reference, 51st edition, Montvale, NJ, Medical Economics Company, Inc. 1997:115

    Google Scholar 

  40. Physicians’ Desk Reference, 52nd edition, Montvale, NJ, Medical Economics Company, Inc. 1998:113

    Google Scholar 

  41. Physicians’ Desk Reference, 52nd edition, Montvale, NJ, Medical Economics Company, Inc. 2000:111

    Google Scholar 

  42. Physicians’ Desk Reference, 51st edition, Montvale, NJ, Medical Economics Company, Inc. 1997:462–463

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Tustin Hospital and Medical Center, Tustin, CA, USA

    Melvin A. Shiffman MD, JD (Chairman)

Authors
  1. Melvin A. Shiffman MD, JD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Shiffman, M.A. (2006). Drugs to Limit Use of or Avoid when Performing Liposuction. In: Liposuction. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28043-X_17

Download citation

  • DOI: https://doi.org/10.1007/3-540-28043-X_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28042-2

  • Online ISBN: 978-3-540-28043-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation